Staphylococcus Aureus
Conditions
Keywords
- Staphylococcus aureus Carriage among Athletes
Brief summary
There are only very few data about the prevalence of CA-MRSA in France and no in athletes. In USA, the clone USA300 is widely disseminated and in Europe the clone ST80 predominates. The aim of the study was to study the carriage of S. aureus in athletes in a French county (Limousin) and to evaluate the proportion of CA-MRSA. The athletes will be met during their training, each one will fill-in a clinical information questionnaire. Nasal, throat, inguinal and skin lesions swab samples will be performed. The antibiotic susceptibility profile of the Staphyloccocus aureus strains isolated will be performed as well as the detection of the PVL gene. Strains will also be typed by different molecular methods (PGFE (Pulsed Gel Field Electrophoresis), SCCmec type (Staphylococcal Chromosome Cassette mec), and MLST (MultiLocus Sequence Typing)). The CIC (Clinical Investigation Center) of the Limoges University Hospital will be in charge of the inclusions of the athletes. The sample analysis will be centralized and performed at the Laboratory of Bacteriology of the Limoges University Hospital. A Clinical Research Officer of the Limoges University Hospital will be in charge of the survey of the study and will organize monthly meetings with all the participants of the study.
Interventions
OTHERNasal, throat, inguinal and skin lesions swab samples will be performed
Nasal, throat, inguinal and skin lesions swab samples will be performed
Sponsors
University Hospital, Limoges
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* adult patients (over 18), * belonging to a sport club of Limousin, practicing rugby, wrestling, basket-ball, volley-ball, hand-ball, fence, martial art, football, weight lifting, and base-ball. * Patient having signed in a free way and lit his consent to participate in this study
Exclusion criteria
* clinical information questionnaire not possible to fill, * swab sample not possible to realize.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Presence of Methicillin-Resistant Staphylococcus aureus in the samples. | 1 year | An athlete is defined as a carrier if at least one strain of Staphylococcus aureus is isolated from one of these samples. A MRSA carrier is defined if the resistance to methicillin has been found for the S. aureus strain isolated in the patient. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Comparison of the MRSA prevalence in athletes according to the sport | 1 year | Comparison of the MRSA prevalence in athletes according to the sport.A strain is considered as PVL positive if the gene encoding the PVL was detected by PCR. |
Outcome results
None listed